Health tech companies often flop. But this researcher’s track record suggests there’s a strategy for success. (STAT)

More reads

• Health tech companies often flop. But this researcher’s track record suggests there’s a strategy for success. (STAT)
• 5 names to know in digital therapeutics: the people behind apps that work like medicines. (STAT Plus)
• Amarin raises sales guidance for heart drug Vascepa, hires more sales reps for larger marketing push. (STAT)
• Elizabeth Warren blasts former FDA commissioner for joining Pfizer’s board. (STAT)